TD Cowen Maintains Tenaya Therapeutics(TNYA.US) With Buy Rating

Futu NewsJan 21 23:32 · Ratings

Promising Advancements in Tenaya Therapeutics' Cardiac Gene Therapy Justify Buy Rating

TipRanksJan 15 15:10 · Ratings

HC Wainwright & Co. Reiterates Buy on Tenaya Therapeutics, Maintains $18 Price Target

BenzingaJan 14 20:17 · Ratings

William Blair Maintains Tenaya Therapeutics(TNYA.US) With Buy Rating

Futu NewsJan 14 06:31 · Ratings

Tenaya Therapeutics Announces Progress In Gene Therapies TN-201 And TN-401 For Cardiomyopathies; Dosing Started In Cohort 2 Of MyPEAK-1 Phase 1b/2 Trial; Cohort 1 Data Expected H1 2025; Initial Data From RIDGE-1 Trial Of TN-401 Expected In H2 2025

BenzingaJan 13 22:39

Tenaya Therapeutics Announces 2025 Strategic Priorities and Anticipated Milestones

GlobeNewswireJan 13 22:16